[go: up one dir, main page]

MD960168A - Metodă şi compuşi pentru tratamentul infecţiilor virale - Google Patents

Metodă şi compuşi pentru tratamentul infecţiilor virale

Info

Publication number
MD960168A
MD960168A MD96-0168A MD960168A MD960168A MD 960168 A MD960168 A MD 960168A MD 960168 A MD960168 A MD 960168A MD 960168 A MD960168 A MD 960168A
Authority
MD
Moldova
Prior art keywords
viral infections
treatment
compounds therefor
compounds
therefor
Prior art date
Application number
MD96-0168A
Other languages
English (en)
Russian (ru)
Inventor
Odur Ayuko Washington
Original Assignee
Radopath Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Limited filed Critical Radopath Limited
Publication of MD960168A publication Critical patent/MD960168A/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Invenţia se referă la o metodă şi compuşi entru tratamentul infecţiilor virale la mamifere.În compuşi se foloseşte flavina şi derivaţi de flavină.Rezultatul tehnic constă în sporirea eficacităţii tratamentului infecţiilor virale.
MD96-0168A 1993-10-19 1996-05-17 Metodă şi compuşi pentru tratamentul infecţiilor virale MD960168A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents
PCT/GB1994/002292 WO1995011028A1 (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents

Publications (1)

Publication Number Publication Date
MD960168A true MD960168A (ro) 1998-04-30

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0168A MD960168A (ro) 1993-10-19 1996-05-17 Metodă şi compuşi pentru tratamentul infecţiilor virale

Country Status (26)

Country Link
EP (1) EP0739208A1 (ro)
JP (1) JPH09505804A (ro)
CN (1) CN1140992A (ro)
AP (1) AP620A (ro)
AU (1) AU7943794A (ro)
BG (1) BG100599A (ro)
BR (1) BR9407862A (ro)
CA (2) CA2123825A1 (ro)
CO (1) CO4520283A1 (ro)
CZ (1) CZ113796A3 (ro)
EE (1) EE9600057A (ro)
GB (2) GB9321558D0 (ro)
HR (1) HRP940688A2 (ro)
HU (1) HUT76322A (ro)
IL (1) IL111338A0 (ro)
JO (1) JO1866B1 (ro)
MA (1) MA23356A1 (ro)
MD (1) MD960168A (ro)
NO (1) NO961547L (ro)
OA (1) OA10579A (ro)
PE (1) PE5596A1 (ro)
PL (1) PL314008A1 (ro)
SK (1) SK50696A3 (ro)
UY (1) UY23844A1 (ro)
WO (1) WO1995011028A1 (ro)
ZA (1) ZA948191B (ro)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (ja) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd インターフェロン用作用効果増強剤及び該増強剤とインターフェロンとを含有する抗ウイルス活性増強組成物
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2003299486A1 (en) * 2002-05-10 2004-06-03 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (it) 2002-07-16 2004-01-16 Dayco Europe Srl Gruppo integrato puleggia-smorzatore torsionale
CN100413866C (zh) * 2002-08-02 2008-08-27 中国人民解放军军事医学科学院放射医学研究所 核黄素衍生物及其制备方法与应用
EP2545788A1 (de) * 2011-07-13 2013-01-16 Martin Hulliger Diätisches Mehrkomponentensystem
JP2018131410A (ja) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 カスパーゼ−３阻害剤とその用途
EP3700512A4 (en) * 2017-10-24 2021-08-11 Lunella Biotech, Inc. MITOFLAVOSCINE: TARGETING FLAVINAL ENZYMES ELIMINATES CANCER STEM CELLS (CSCS) BY INHIBITING MITOCHONDRIAL BREATHING
BR112022000175A2 (pt) * 2019-07-09 2022-02-22 Dsm Ip Assets Bv Reduzindo a atividade viral de elafibranor com riboflavina ou dha

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (fr) * 1991-04-02 1995-03-10 Jean Berque Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (ja) * 1992-03-27 2000-08-07 雪印乳業株式会社 シアル酸結合５−デアザフラビン系化合物

Also Published As

Publication number Publication date
IL111338A0 (en) 1994-12-29
EP0739208A1 (en) 1996-10-30
JO1866B1 (en) 1995-12-27
AU7943794A (en) 1995-05-08
HU9601006D0 (en) 1996-06-28
AP9400695A0 (en) 1995-01-31
CN1140992A (zh) 1997-01-22
CZ113796A3 (en) 1996-11-13
GB2283913A (en) 1995-05-24
AP620A (en) 1997-10-14
HRP940688A2 (en) 1997-04-30
CA2123825A1 (en) 1995-04-20
CO4520283A1 (es) 1997-10-15
SK50696A3 (en) 1997-01-08
GB9321558D0 (en) 1993-12-08
PL314008A1 (en) 1996-08-05
GB9421099D0 (en) 1994-12-07
BG100599A (en) 1997-02-28
NO961547L (no) 1996-06-19
OA10579A (en) 2002-06-19
ZA948191B (en) 1995-06-08
PE5596A1 (es) 1996-04-18
MA23356A1 (fr) 1995-07-01
UY23844A1 (es) 1995-03-28
CA2174552A1 (en) 1995-04-27
BR9407862A (pt) 1997-05-20
HUT76322A (en) 1997-08-28
NO961547D0 (no) 1996-04-18
EE9600057A (et) 1996-10-15
WO1995011028A1 (en) 1995-04-27
JPH09505804A (ja) 1997-06-10

Similar Documents

Publication Publication Date Title
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
MY101842A (en) Treatment of oral diseases.
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
MX9702932A (es) L-ribofuranosilnucleosidos.
AU2500097A (en) Compositions containing bacteriophages and methods of using bacteriophages to treat infections
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DK0973735T3 (da) Polyaromatiske antivirale præparater
MD1838G2 (ro) Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
UA41355C2 (uk) Засіб для лікування нейро-сніду
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
FI945000A0 (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
AU3206297A (en) Composition and method for treating herpes simplex
MX9702926A (es) L-eritrosilnucleosidos.
AU6796287A (en) Method and composition for prophylaxis and treatment of viral infections
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
ZA87470B (en) Method and composition for prophylaxis and treatment of viral infections
FI965114A7 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
ZA949564B (en) Method for treating constipation using dimeticone.
FI944687L (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
AU4829190A (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
AU7120987A (en) Composition for and method of treating aids and certain related diseases

Legal Events

Date Code Title Description
FA1A Withdrawn application

Free format text: 19990225